XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating Expenses:    
Research and development $ 10,553 $ 5,430
General and administrative 3,549 3,543
Total operating expenses 14,102 8,973
Loss from operations (14,102) (8,973)
Other income (expense):    
Grant income 4,912 3,426
Other income (expense), net 244 (615)
Interest expense (10) (10)
Loss on currency translation from liquidation of subsidiary (195)  
Total other income, net 4,951 2,801
Net loss (9,151) (6,172)
Foreign currency translation adjustment, including reclassifications 195 4
Total comprehensive loss $ (8,956) $ (6,168)
Net loss per share, basic (in dollars per share) $ (0.27) $ (0.21)
Net loss per share, diluted (in dollars per share) $ (0.27) $ (0.21)
Weighted-average common shares outstanding, basic (in shares) 33,735,269 29,094,592
Weighted-average common shares outstanding, diluted (in shares) 33,735,269 29,094,592